Evaluation of digestive tolerance of a soluble corn fibre.
BACKGROUND
To assess consumers' acceptance of a new fibre, it is essential to evaluate its digestive tolerance after ingestion. We aimed to determine the tolerance of increasing dosages of Promitor™ Soluble Gluco Fibre (SGF; Tate&Lyle, Hoffman Estates, IL, USA) up to 70 g fibre per day using a validated gastrointestinal composite score.


METHODS
A composite score of gastrointestinal tolerance integrating gastrointestinal symptoms, stool frequency and consistency was applied. To statistically validate this composite score, the gastrointestinal tolerance of inulin (10 g versus 20 g containing, respectively, 9 g versus 18 g of fibre) was assessed in 18 healthy volunteers in a randomised double-blind placebo-controlled cross-over study. Second, in a double-blind placebo-controlled cross-over study with 20 healthy volunteers, the gastrointestinal tolerance of SGF in both acute and 'spread over the day' conditions of consumption was assessed.


RESULTS
By contrast to 10 g, 20 g of inulin demonstrated a significant difference in composite score compared to placebo [P < 0.001, difference = 7.6; 95% confidence interval (CI) = 3.8-11.3]. These values were considered as reference during the second study. In acute conditions, 40 g of SGF fibre was the highest (threshold) dose tested that indicates the digestive tolerance criteria (difference from placebo on the composite score <7.6 and upper limit of the 95% CI <11.3); this is twice the amount tolerated for inulin. In 'spread over the day' conditions, 65 g of SGF fibre was the threshold dose (P < 0.001, difference = 6.5; 95% CI = 3.4-9.5).


CONCLUSIONS
The results of the present study demonstrate that 40 g of SGF fibre, when consumed as a single dose, and 65 g of SGF fibre, when consumed in multiple-doses, across the day are well-tolerated by healthy volunteers.
Biofortis, Bio Ouest -île de Nantes, Nantes, France.
B
B
Housez
M
M
Cazaubiel
C
C
Vergara
J-M
JM
Bard
A
A
Adam
A
A
Einerhand
P
P
Samuel
D000293:Adolescent; D000328:Adult; D000368:Aged; D018592:Cross-Over Studies; D003672:Defecation / Q000187:drug effects* / Q000502:physiology; D004043:Dietary Fiber / Q000008:administration & dosage / Q000494:pharmacology*; D004064:Digestive System / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005243:Feces / Q000737:chemistry; D005260:Female; D005414:Flatulence / Q000453:epidemiology; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007444:Inulin / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D012995:Solubility; D055815:Young Adult; D003313:Zea mays
D004043:Dietary Fiber; D007444:Inulin